ANHEART

Serial Number 97976206
Registration 7191277
700

Registration Progress

Application Filed
Jan 21, 2022
Under Examination
Jan 31, 2023
Approved for Publication
Dec 6, 2022
Published for Opposition
Dec 6, 2022
Registered
Oct 10, 2023

Trademark Image

ANHEART

Basic Information

Serial Number
97976206
Registration Number
7191277
Filing Date
January 21, 2022
Registration Date
October 10, 2023
Published for Opposition
December 6, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 10, 2023
Registration
Registered
Classes
042

Rights Holder

NUVATION BIO INC.

03
Address
1500 BROADWAY, SUITE 1401
NEW YORK, NY 10036

Ownership History

AnHeart Therapeutics Inc.

Original Applicant
03
New York, NY

AnHeart Therapeutics Inc.

Owner at Publication
03
New York, NY

AnHeart Therapeutics Inc.

Original Registrant
03
New York, NY

ANHEART THERAPEUTICS LLC

New Owner After Registration #1
16
NEW YORK, NY

NUVATION BIO INC.

New Owner After Registration #2
03
NEW YORK, NY

Legal Representation

Attorney
Jenifer deWolf Paine

USPTO Deadlines

Next Deadline
1357 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231010)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Mar 19, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 20, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 10, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 10, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 7, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 6, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 9, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 8, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 11, 2023 IUAF S USE AMENDMENT FILED Loading...
Aug 8, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jul 11, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jul 31, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 11, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jul 11, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 31, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 6, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 6, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical products development; Research in the field of pharmaceuticals
First Use Anywhere: Oct 9, 2021
First Use in Commerce: Oct 9, 2021

Additional Information

Design Mark
The mark consists of the stylized wording "ANHEART".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
AN HEART

Classification

International Classes
042